Chikungunya isn't prevalent in the U.S., but travelers are being told to be cautious about getting the vaccine for the ...

The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...

Adults over the age of 60 are recommended not to get the chikungunya vaccine to prevent the mosquito-borne illness due to two ...

Bhopal: In Madhya Pradesh, chikungunya cases have risen significantly, matching the increase in dengue infections, creating public health challenges a.

The U.S. government is advising that international travelers age 60 and older not get a chikungunya vaccine as it ...

The CDC began recommending Ixchiq last year for adults traveling to countries where chikungunya is common. The vaccine uses a ...

The Trump administration's FDA and CDC is advising U.S. patients using the drug Ixchiq to hold off while U.S. health ...

A new study published Thursday warns that tiger mosquitoes are increasingly spreading to Europe because of climate change, ...

There has been a noticeable increase in the spread of Chikungunya in the city of Colombo, Kotte, and the suburbs of Colombo, ...

The feverish diseases dengue and chikungunya could soon become endemic in Europe as the tiger mosquitoes that transmit these ...

A total of 19,901 dengue cases have been reported in the country so far this year, according to the National Dengue Control ...

The CDC recommends the vaccine pause while it investigates “serious adverse events,” including neurologic and cardiac events.